drugset / Trial / NCT01483651

Physiologic Response to Glucagon at Varying Insulin Levels

NCT01483651

RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of this research study is to test how different levels of insulin block the effect of glucagon. Insulin is a hormone that lowers blood glucose. Glucagon raises blood glucose. Both are natural hormones made by people without diabetes. Sensor-based blood glucose control studies have been done by our research group using glucagon in small doses to prevent hypoglycemia (low blood sugar). However, sometimes glucagon does not work to raise blood sugar. The investigators believe this is because of too much insulin in the body. This study will help determine how different levels of insulin in the body affect the ability of glucagon to raise blood sugar.

Timeline

Start
2011-11
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucagon Peptide 10 ug Subcutaneous
Subject Glucagon Peptide 25 ug Subcutaneous
Subject Glucagon Peptide 45 ug Subcutaneous
Subject Glucagon Peptide 70 ug Subcutaneous
Subject Glucagon Peptide 100 ug Subcutaneous
Subject Glucagon Peptide 135 ug Subcutaneous
Subject Glucagon Peptide 175 ug Subcutaneous
Subject Insulin Protein / enzyme biologic 0.01 iu/kg Intravenous
Subject Insulin Protein / enzyme biologic 0.02 iu/kg Intravenous
Subject Insulin Protein / enzyme biologic 0.04 iu/kg Intravenous
Subject Insulin Protein / enzyme biologic 0.08 iu/kg Intravenous